Patents by Inventor Glen Deloid

Glen Deloid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR REDUCING BIOAVAILABILITY AND ABSORPTION OF INGESTED SUBSTANCES
    Publication number: 20210030782
    Abstract: Methods for reducing at least one of the bioavailability and absorption of at least one of ingested fat, carbohydrates, and unwanted substances from foodstuff in a subject are disclosed. The methods described herein include administering an amount of a nanobiopolymer, or combinations of nanobiopolymers, sufficient to reduce at least one of the bioavailability and absorption of ingested fat, carbohydrates, and unwanted substances to a subject, such as a human subject.
    Type: Application
    Filed: November 9, 2018
    Publication date: February 4, 2021
    Inventors: Philip Demokritou, Glen Deloid, Kee Woei Ng, Joachim Loo
  • Methods of measuring effective density of nanoparticle agglomerates dispersed in a liquid using centrifugation
    Patent number: 9360408
    Abstract: The invention includes a method of determining the effective density of nanomaterial agglomerates in liquids, such as but not limited to physiological fluids, using volumetric centrifugation. The method of the invention allows for the development of reliable and efficient in vitro dosimetry and methods for toxicological testing of engineered nanomaterials.
    Type: Grant
    Filed: June 20, 2013
    Date of Patent: June 7, 2016
    Assignee: President and Fellows of Harvard College
    Inventors: Philip Demokritou, Glen Deloid, Joel Cohen
  • NOVEL METHODS OF MEASURING EFFECTIVE DENSITY OF NANOPARTICLES IN FLUIDS
    Publication number: 20150140597
    Abstract: The invention includes a method of determining the effective density of nanomaterial agglomerates in liquids, such as but not limited to physiological fluids, using volumetric centrifugation. The method of the invention allows for the development of reliable and efficient in vitro dosimetry and methods for toxicological testing of engineered nanomaterials.
    Type: Application
    Filed: June 20, 2013
    Publication date: May 21, 2015
    Inventors: Philip Demokritou, Glen Deloid, Joel Cohen